Departments
In reply: Intensive therapy of type 2 diabetes (ACCORD trial) (October 2008)
Byron J. Hoogwerf, MD
Cleveland Clinic Journal of Medicine February 2009, 76 (2) 83-84; DOI: https://doi.org/10.3949/ccjm.76c.01003
Byron J. Hoogwerf
Eli Lilly and Company, US Endocrinology-Diabetes Care, Principal Investigator (Cleveland Clinic Site), ACCORD Study Group
This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Cleveland Clinic Journal of Medicine
Vol. 76, Issue 2
1 Feb 2009
In reply: Intensive therapy of type 2 diabetes (ACCORD trial) (October 2008)
Byron J. Hoogwerf
Cleveland Clinic Journal of Medicine Feb 2009, 76 (2) 83-84; DOI: 10.3949/ccjm.76c.01003
Jump to section
Related Articles
- No related articles found.
Cited By...
- No citing articles found.